@article{7061a983fab04b53a256ce0bcaf865cf,
title = "Establishing a nephrology genetic clinic",
keywords = "clinical molecular testing, hereditary kidney disease, monogenic kidney disease",
author = "{Pinto e Vairo}, Filippo and Kemppainen, {Jennifer L.} and Lieske, {John C.} and Harris, {Peter C.} and Hogan, {Marie C.}",
note = "Funding Information: PCH receives research grants from Acceleron, Jemincare, Navitor, and Otsuka Pharmaceuticals; consulting activities for Caraway Therapeutics, Mitobridge, Otsuka Pharmaceuticals, and Regulus; and is member of the Advisory Board of Vertex Pharmaceuticals. JCL receives research grants and participates on Advisory Boards for Dicerna, Allena, OxThera, and Alnylam; and is member of the Advisory Board for Ofan-Bridgebio, Synlogic, Novobiome, and Oxidien. All the other authors declared no competing interests.",
year = "2021",
month = aug,
doi = "10.1016/j.kint.2021.05.008",
language = "English (US)",
volume = "100",
pages = "254--259",
journal = "Kidney international",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",
}